366 related articles for article (PubMed ID: 21333700)
1. Prodrugs for improving tumor targetability and efficiency.
Mahato R; Tai W; Cheng K
Adv Drug Deliv Rev; 2011 Jul; 63(8):659-70. PubMed ID: 21333700
[TBL] [Abstract][Full Text] [Related]
2. Current prodrug design for drug discovery.
Hsieh PW; Hung CF; Fang JY
Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
[TBL] [Abstract][Full Text] [Related]
3. Prodrug design of phenolic drugs.
Férriz JM; Vinsová J
Curr Pharm Des; 2010; 16(18):2033-52. PubMed ID: 20443775
[TBL] [Abstract][Full Text] [Related]
4. Prodrug strategies in anticancer chemotherapy.
Kratz F; Müller IA; Ryppa C; Warnecke A
ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
[TBL] [Abstract][Full Text] [Related]
5. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
[TBL] [Abstract][Full Text] [Related]
6. Recent trends in targeted anticancer prodrug and conjugate design.
Singh Y; Palombo M; Sinko PJ
Curr Med Chem; 2008; 15(18):1802-26. PubMed ID: 18691040
[TBL] [Abstract][Full Text] [Related]
7. Prodrugs as drug delivery system in oncology.
Delahousse J; Skarbek C; Paci A
Cancer Chemother Pharmacol; 2019 Nov; 84(5):937-958. PubMed ID: 31392391
[TBL] [Abstract][Full Text] [Related]
8. Prodrugs in cancer chemotherapy.
Connors TA; Knox RJ
Stem Cells; 1995 Sep; 13(5):501-11. PubMed ID: 8528099
[TBL] [Abstract][Full Text] [Related]
9. Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy.
Dragojevic S; Ryu JS; Raucher D
Molecules; 2015 Dec; 20(12):21750-69. PubMed ID: 26690101
[TBL] [Abstract][Full Text] [Related]
10. Advances in oral delivery of anti-cancer prodrugs.
Jain AK; Jain S
Expert Opin Drug Deliv; 2016 Dec; 13(12):1759-1775. PubMed ID: 27292717
[TBL] [Abstract][Full Text] [Related]
11. Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment.
Edupuganti VVSR; Tyndall JDATDA; Gamble AB
Recent Pat Anticancer Drug Discov; 2021; 16(4):479-497. PubMed ID: 33966624
[TBL] [Abstract][Full Text] [Related]
12. Targeted enzyme prodrug therapies.
Schellmann N; Deckert PM; Bachran D; Fuchs H; Bachran C
Mini Rev Med Chem; 2010 Sep; 10(10):887-904. PubMed ID: 20560876
[TBL] [Abstract][Full Text] [Related]
13. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy.
Mukerabigwi JF; Yin W; Zha Z; Ke W; Wang Y; Chen W; Japir AAMM; Wang Y; Ge Z
J Control Release; 2019 Jun; 303():209-222. PubMed ID: 31026547
[TBL] [Abstract][Full Text] [Related]
14. Strategies on the development of small molecule anticancer drugs for targeted therapy.
Lu YH; Gao XQ; Wu M; Zhang-Negrerie D; Gao Q
Mini Rev Med Chem; 2011 Jun; 11(7):611-24. PubMed ID: 21699492
[TBL] [Abstract][Full Text] [Related]
15. Drug Conjugates Using Different Dynamic Covalent Bonds and their Application in Cancer Therapy.
Theodosis-Nobelos P; Charalambous D; Triantis C; Rikkou-Kalourkoti M
Curr Drug Deliv; 2020; 17(7):542-557. PubMed ID: 32384029
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of anticancer drugs II: the prodrug strategy.
Mazzaferro S; Bouchemal K; Ponchel G
Drug Discov Today; 2013 Jan; 18(1-2):93-8. PubMed ID: 22960308
[TBL] [Abstract][Full Text] [Related]
17. ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.
Peng X; Gandhi V
Ther Deliv; 2012 Jul; 3(7):823-33. PubMed ID: 22900465
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles as delivery carriers for anticancer prodrugs.
Fang JY; Al-Suwayeh SA
Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
[TBL] [Abstract][Full Text] [Related]
19. Prodrugs: a challenge for the drug development.
Zawilska JB; Wojcieszak J; Olejniczak AB
Pharmacol Rep; 2013; 65(1):1-14. PubMed ID: 23563019
[TBL] [Abstract][Full Text] [Related]
20. Prodrugs for targeted cancer therapy.
Souza C; Pellosi DS; Tedesco AC
Expert Rev Anticancer Ther; 2019 Jun; 19(6):483-502. PubMed ID: 31055990
[No Abstract] [Full Text] [Related]
[Next] [New Search]
